Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Nordic BioVentures is a Copenhagen-based venture creation studio founded to operate at the intersection of life sciences and planetary health. Established by co-founders Josephine Schroder and Will Wright, the organization emphasizes a consultative approach, working closely with early-stage life science founders and organizations to build and validate new ventures. The studio model allows Nordic BioVentures to focus on innovation without the constraints of traditional venture capital funding.
Currently, Nordic BioVentures operates with a small team of 1-10 employees and is bootstrapped, relying on revenue generated from consulting and innovation program delivery. The firm consults with over 100 life science startups annually, partnering with universities, established venture capital firms, and deeptech NGOs to foster innovation and growth in the life sciences sector. Their work aligns with the United Nations Sustainable Development Goals, particularly those focused on climate action and health.
Nordic BioVentures invests in and provides services related to healthcare and pharmaceutical technologies, emphasizing the application of advanced artificial intelligence and data engineering. Their investment strategy is centered on building and validating ventures that address both health outcomes and planetary health challenges. The firm operates primarily in Europe, with a strong focus on the Nordic region, where it engages with the local biotech community.
The organization seeks to partner with early-stage life science founders who are committed to innovation and sustainability. Nordic BioVentures values projects that leverage technology to create impactful solutions in healthcare and climate-related fields. Their consultative approach allows them to tailor their support to the specific needs of each venture, ensuring that they can effectively contribute to the development of groundbreaking technologies.
Nordic BioVentures does not operate as a traditional venture capital firm and does not deploy capital into startups. Instead, they consult with over 100 life science startups annually, providing tailored support and guidance. While specific portfolio companies are not disclosed, the firm collaborates with various organizations in the healthcare and pharmaceutical sectors, focusing on ventures that align with their mission of improving health outcomes and addressing planetary health challenges.
Through their partnerships with universities, established VCs, and deeptech NGOs, Nordic BioVentures plays a significant role in the Nordic life sciences ecosystem. Their consultative model allows them to engage with a diverse range of projects, fostering innovation across multiple sectors, including healthcare, biotech, AI, and climate.
Josephine Schroder - Co-founder & Managing Partner. Josephine has extensive experience in the life sciences sector and has played a pivotal role in establishing Nordic BioVentures as a key player in the venture creation space.
Will Wright - Co-founder & Managing Partner. Will brings a wealth of knowledge in venture development and has been instrumental in guiding the firm's consultative approach to supporting startups.
Max van 't Hof - Venture Development Associate. Max contributes to the firm's efforts in consulting and supporting life science startups, leveraging his expertise in venture development.
Startups interested in pitching to Nordic BioVentures should reach out through their website. It is advisable to include a clear overview of the startup's vision, the problem it aims to solve, and how it aligns with Nordic BioVentures' focus on healthcare and sustainability. While there is no formal application process, initial discussions are crucial for establishing a mutual understanding.
Response times may vary, but founders can expect to engage in a dialogue that explores the potential for collaboration and support.
Nordic BioVentures runs a tailored innovation program designed to support early-stage life science startups. This program focuses on building and validating ventures in healthcare and pharmaceutical technologies, leveraging advanced data engineering and artificial intelligence.
Eligibility for the program typically includes early-stage startups in the life sciences sector that are committed to sustainability and innovation. Interested founders can apply through the Nordic BioVentures website, where they can find more information about the program and its offerings.
As of March 2026, Nordic BioVentures continues to consult with over 100 life science startups annually, reinforcing its position within the Nordic biotech community. The firm remains focused on its mission to improve health outcomes through innovative technologies and partnerships.
Recent activities include ongoing collaborations with universities and deeptech NGOs, further enhancing their consultative model and expanding their impact in the life sciences sector.
What are Nordic BioVentures' investment criteria?
Nordic BioVentures focuses on healthcare and pharmaceutical technologies, particularly those that leverage advanced data engineering and artificial intelligence. They seek to partner with early-stage life science founders who are committed to sustainability and innovation.
How can startups apply or pitch to Nordic BioVentures?
Startups interested in collaborating with Nordic BioVentures should reach out through their website. They emphasize a consultative approach, so initial discussions often focus on understanding the startup's vision and needs.
What makes Nordic BioVentures different from traditional VC firms?
Unlike traditional venture capital firms, Nordic BioVentures operates as a venture creation studio. They do not deploy capital into startups but instead provide consulting services and support to help founders build and validate their ventures.
What is the geographic scope of Nordic BioVentures?
Nordic BioVentures primarily operates in Europe, with a strong focus on the Nordic region. They engage with local biotech communities and collaborate with universities and organizations across the continent.
What kind of post-investment involvement does Nordic BioVentures have?
As a venture creation studio, Nordic BioVentures works closely with the startups they consult, providing ongoing support and guidance throughout the venture development process. This includes assistance with validation, strategy, and operational challenges.
What is the size of Nordic BioVentures' fund or check size?
Nordic BioVentures does not operate a traditional fund and is bootstrapped. They do not deploy capital into startups, focusing instead on consulting and innovation program delivery.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.